U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H27Cl2N5O3S
Molecular Weight 572.506
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of JD-5037

SMILES

CC(C)[C@H](N\C(=N/S(=O)(=O)C1=CC=C(Cl)C=C1)N2C[C@@H](C(=N2)C3=CC=C(Cl)C=C3)C4=CC=CC=C4)C(N)=O

InChI

InChIKey=GTCSIQFTNPTSLO-RPWUZVMVSA-N
InChI=1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1

HIDE SMILES / InChI

Molecular Formula C27H27Cl2N5O3S
Molecular Weight 572.506
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry
Defined Stereocenters 2 / 2
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.35 nM [Ki]
PubMed

PubMed

TitleDatePubMed
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
2016 Dec
Synthesis of S-2-((S)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-(methyl-d3 )butanamide-d5 , octadeuterated JD5037.
2017 Aug
Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo.
2017 Aug
Amplitude-selective filtering for remote-PPG.
2017 Mar 1
Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling.
2017 Oct
Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
2018 Feb
Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis.
2019 Dec
Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics.
2019 Mar
Dual inhibition of cannabinoid CB1 receptor and inducible NOS attenuates obesity-induced chronic kidney disease.
2020 Jan
Substance Class Chemical
Created
by admin
on Tue Oct 22 09:09:24 UTC 2019
Edited
by admin
on Tue Oct 22 09:09:24 UTC 2019
Record UNII
ENZ75DG2Z6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
JD-5037
Common Name English
BUTANAMIDE, 2-((((4S)-3-(4-CHLOROPHENYL)-4,5-DIHYDRO-4-PHENYL-1H-PYRAZOL-1-YL)(((4-CHLOROPHENYL)SULFONYL)AMINO)METHYLENE)AMINO)-3-METHYL-, (2S)-
Systematic Name English
Code System Code Type Description
CAS
1392116-14-1
Created by admin on Tue Oct 22 09:09:24 UTC 2019 , Edited by admin on Tue Oct 22 09:09:24 UTC 2019
PRIMARY
PUBCHEM
66553204
Created by admin on Tue Oct 22 09:09:24 UTC 2019 , Edited by admin on Tue Oct 22 09:09:24 UTC 2019
PRIMARY
Related Record Type Details
TARGET->INVERSE AGONIST
METABOLIC ENZYME -> INHIBITOR
at 10 ?M 80% inhibition
IC50